Replies to post #153438 on Biotech Values

[DewDiligence]

Re: GSK pipeline

http://www.reuters.com/article/2012/12/03/us-glaxosmithkline-pipeline-idUSBRE8B20O220121203

GlaxoSmithKline expects to have pivotal clinical trial results on up to 14 medicines in the next two years, including two new products which - if they work - could change the way cancer and heart disease are treated.

…Key experimental drugs that will have results from final-stage Phase III clinical trials in 2013 and 2014 include the heart drug darapladib and therapeutic cancer vaccine MAGE-A3, the company said in a briefing to investors and analysts.